Tharimmune, Inc. Files 8-K with Corporate Updates
Ticker: CNTN · Form: 8-K · Filed: Mar 11, 2024 · CIK: 1861657
| Field | Detail |
|---|---|
| Company | Tharimmune, INC. (CNTN) |
| Form Type | 8-K |
| Filed Date | Mar 11, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, amendment, financials
Related Tickers: THAR
TL;DR
Tharimmune (THAR) filed an 8-K with corporate updates and financials.
AI Summary
On March 7, 2024, Tharimmune, Inc. filed an 8-K report detailing amendments to its Articles of Incorporation and the filing of financial statements and exhibits. The company, formerly known as Hillstream BioPharma Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing provides essential updates on Tharimmune's corporate structure and financial reporting, which are crucial for investors to understand the company's current status and compliance.
Risk Assessment
Risk Level: low — This is a routine corporate filing (8-K) reporting amendments and exhibits, not indicating significant new risks or events.
Key Players & Entities
- Tharimmune, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Hillstream BioPharma Inc. (company) — Former company name
- March 7, 2024 (date) — Date of earliest event reported
FAQ
What specific amendments were made to Tharimmune's Articles of Incorporation?
The filing indicates amendments to the Articles of Incorporation were made, but the specific details of these amendments are not provided in the provided text excerpt.
What financial statements and exhibits are being filed with this 8-K?
The filing states that Financial Statements and Exhibits are being filed, but the specific list or content of these documents is not detailed in the provided text.
When was Tharimmune, Inc. formerly known as Hillstream BioPharma Inc.?
The name change from Hillstream BioPharma Inc. to Tharimmune, Inc. occurred on September 25, 2023.
What is Tharimmune, Inc.'s Standard Industrial Classification (SIC) code?
Tharimmune, Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is Tharimmune, Inc.'s principal executive office located?
Tharimmune, Inc.'s principal executive office is located at 1200 Route 22 East, Suite 2000, Bridgewater, NJ 08807.
Filing Stats: 532 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-03-11 16:15:32
Key Financial Figures
- $0.0001 — nge on which registered Common stock, $0.0001 par value THAR The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex3-1.htm (EX-3.1) — 8KB
- 0001493152-24-009575.txt ( ) — 220KB
- thar-20240307.xsd (EX-101.SCH) — 3KB
- thar-20240307_lab.xml (EX-101.LAB) — 33KB
- thar-20240307_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: March 11, 2024 Tharimmune, Inc. /s/ Randy Milby Randy Milby Chief Executive Officer